ICH Reformed At Last, Expects More Drug Regulators To Join In
This article was originally published in SRA
Executive Summary
The International Conference of Harmonisation has at last finalized its organizational reforms that are expected to encourage the group's expansion beyond its current membership of regulators from five regions (Canada, the EU, Japan, Switzerland and the US) and three research-based pharmaceutical industry associations (from the EU, Japan and the US)1.
You may also be interested in...
ICH Evaluates Guideline Uptake By New And Old Members
The study will be undertaken by an independent third party and its results will help facilitate a transparent dialogue on the long-term goal of ensuring that all the ICH regulators implement all the ICH guidelines.
ICH Opens Up Management Committee To Regulators From China, Singapore, South Korea
The ICH has now largely finished implementing its structural and organizational reforms by adding new regulatory and industry members to the organization. The reform process aims to increase ICH's international outreach and turn it into a “truly global initiative.”
'Historical Moment' As Global Generics Body Gets Seat On ICH Management Committee
The move recognizes the expertise that generic and biosimilar drug developers can bring to the scientific discussions at the International Council on Harmonisation.